Trial Outcomes & Findings for To Evaluate The Performance Of Two Monthly Replacement Silicone Hydrogel Contact Lenses After 1-month Of Wear (NCT NCT05333965)

NCT ID: NCT05333965

Last Updated: 2023-10-23

Results Overview

Lens handling on removal will be measured on a scale of 0-10, 0.5 steps (0=Completely dissatisfied,10=Completely satisfied)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

26 participants

Primary outcome timeframe

1 month

Results posted on

2023-10-23

Participant Flow

There were 27 people screened and 26 were dispensed with study products. Two participants discontinued and 24 completed the study.

Participant milestones

Participant milestones
Measure
Lens A, Then Lens B
Participants wore Lens A for one month and then crossed over to wear Lens B for one month. Each Lens type was worn on a daily wear basis for one month.
Lens B, Then Lens A
Participants wore Lens B for one month and then crossed over to wear Lens A for one month. Each Lens type was worn on a daily wear basis for one month.
First Intervention
STARTED
13
13
First Intervention
COMPLETED
13
11
First Intervention
NOT COMPLETED
0
2
Second Intervention
STARTED
13
11
Second Intervention
COMPLETED
13
11
Second Intervention
NOT COMPLETED
0
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Lens A, Then Lens B
Participants wore Lens A for one month and then crossed over to wear Lens B for one month. Each Lens type was worn on a daily wear basis for one month.
Lens B, Then Lens A
Participants wore Lens B for one month and then crossed over to wear Lens A for one month. Each Lens type was worn on a daily wear basis for one month.
First Intervention
Adverse Event
0
1
First Intervention
Withdrawal by Subject
0
1

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Analysis Population
n=24 Participants
Out of 26 participants, 2 of them discontinued. Therefore, overall base participants (Analysis population) are 24.
Age, Categorical
<=18 years
0 Participants
n=24 Participants
Age, Categorical
Between 18 and 65 years
24 Participants
n=24 Participants
Age, Categorical
>=65 years
0 Participants
n=24 Participants
Age, Continuous
31.4 years
STANDARD_DEVIATION 14.1 • n=24 Participants
Sex: Female, Male
Female
15 Participants
n=24 Participants
Sex: Female, Male
Male
9 Participants
n=24 Participants

PRIMARY outcome

Timeframe: 1 month

Lens handling on removal will be measured on a scale of 0-10, 0.5 steps (0=Completely dissatisfied,10=Completely satisfied)

Outcome measures

Outcome measures
Measure
Lens A
n=24 Participants
Participants wore Lens A for 1 month.
Lens B
n=24 Participants
Participants wore Lens B for 1 month.
Lens Handling on Lens Removal
8.4 units on a scale
Standard Deviation 2.3
8.9 units on a scale
Standard Deviation 1.3

Adverse Events

Lens A

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Lens B

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Lens A
n=26 participants at risk
Participants wore Lens A for 1 month.
Lens B
n=26 participants at risk
Participants wore Lens B for 1 month.
Eye disorders
Significant Ocular Redness
0.00%
0/26 • From dispense up to one month on each study lens, for total of two months
Enrollment population (n=26)
3.8%
1/26 • Number of events 2 • From dispense up to one month on each study lens, for total of two months
Enrollment population (n=26)
Eye disorders
asymptomatic corneal infiltrate keratitis
0.00%
0/26 • From dispense up to one month on each study lens, for total of two months
Enrollment population (n=26)
3.8%
1/26 • Number of events 2 • From dispense up to one month on each study lens, for total of two months
Enrollment population (n=26)

Additional Information

Jose A. Vega, OD, MSc, FAAO

CooperVision

Phone: 9256213761

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place